A randomised clinical study comparing the effect of Steareth 30 and SLS containing toothpastes on oral epithelial integrity (desquamation).


Journal

Journal of dentistry
ISSN: 1879-176X
Titre abrégé: J Dent
Pays: England
ID NLM: 0354422

Informations de publication

Date de publication:
01 2019
Historique:
received: 09 10 2018
revised: 06 11 2018
accepted: 12 11 2018
entrez: 31 1 2019
pubmed: 31 1 2019
medline: 11 3 2020
Statut: ppublish

Résumé

To compare the clinical effect of toothpastes containing Steareth 30 and SLS (sodium lauryl sulphate) surfactants on oral epithelial integrity (desquamation) using a new Oral Mucosal Sloughing Index (OMSI). 30 volunteers participated in a single centre, double-blind, randomised, crossover clinical study. After a lead-in, subjects were allocated to the first test toothpaste, which was applied to the maxilla via a cap splint, followed by whole mouth brushing with the respective toothpaste and rinsing with the toothpaste slurry. Soft desquamation (lesion status) was assessed using a novel Oral Mucosal Sloughing Index (OMSI). Soft tissue status was measured at baseline (prior to test product use), 30 min following test product application and 4 days later following "at home" use of test toothpaste. After a wash out period, soft tissue assessment and product use were repeated for the remaining toothpaste. Using the OMSI, 30 min post-application, significantly fewer lesion counts (all sites) were observed for the Steareth 30 toothpaste compared to SLS toothpaste (p < 0.0001). Additionally, 30 min after toothpaste use, the average lesion severity score was significantly lower for the Steareth 30 toothpaste compared to SLS toothpaste (p < 0.0001). There were no significant differences in lesion status at baseline or following 4 days of "at home" use of the toothpastes. No product related adverse events were reported. Using an Oral Mucosal Sloughing Index for assessment, application of a toothpaste containing Steareth 30 generated significantly less transient soft tissue desquamation (fewer lesion counts and lower severity) than a toothpaste containing SLS. Treatment with a toothpaste containing Steareth 30 surfactant generated fewer transient soft tissue lesions (lower desquamation) compared to a toothpaste containing SLS surfactant.

Identifiants

pubmed: 30696554
pii: S0300-5712(18)30641-9
doi: 10.1016/j.jdent.2018.11.005
pii:
doi:

Substances chimiques

Surface-Active Agents 0
Toothpastes 0
Sodium Dodecyl Sulfate 368GB5141J
Polyethylene Glycols 3WJQ0SDW1A
octadecyl polyoxyethylene ether 9005-00-9

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S33-S39

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

A Green (A)

Unilever Oral Care, Quarry Road East, Bebington, Wirral, CH63 3JW, UK. Electronic address: alison.green@unilever.com.

S Crichard (S)

Birmingham Dental Hospital and School of Dentistry, 5 Mill Pool Way, Birmingham, B5 7EG, UK. Electronic address: S.D.Crichard@bham.ac.uk.

N Ling-Mountford (N)

Birmingham Dental Hospital and School of Dentistry, 5 Mill Pool Way, Birmingham, B5 7EG, UK. Electronic address: N.A.Ling@bham.ac.uk.

M Milward (M)

Birmingham Dental Hospital and School of Dentistry, 5 Mill Pool Way, Birmingham, B5 7EG, UK. Electronic address: m.r.milward@bham.ac.uk.

N Hubber (N)

Birmingham Dental Hospital and School of Dentistry, 5 Mill Pool Way, Birmingham, B5 7EG, UK. Electronic address: N.Hubber@bham.ac.uk.

S Platten (S)

Unilever Oral Care, Quarry Road East, Bebington, Wirral, CH63 3JW, UK. Electronic address: Suzanne.Platten@Unilever.com.

A K Gupta (AK)

Hindustan Unilever Limited Research Centre, Main Road, Whitefield, Bangalore 560 066, India. Electronic address: AshokKumar.Gupta@unilever.com.

I L C Chapple (ILC)

Birmingham Dental Hospital and School of Dentistry, 5 Mill Pool Way, Birmingham, B5 7EG, UK. Electronic address: i.l.c.chapple@bham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH